Clinical Trials

28 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT03121079 2020-09-23

Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation

Phase NA Withdrawn

Recurrence, Leukemia, Myeloid, Acute

NCT00003727 2019-11-04

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia

22 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00004088 2019-07-02

Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma

77 enrolled 15 charts

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00002835 2018-11-15

Combination Chemotherapy in Treating Patients With Lymphoma

116 enrolled

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00363649 2018-11-13

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

36 enrolled 13 charts

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00038376 2018-10-29

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

LymphoidOther hematologic neoplasm

56 enrolled

Mycosis Fungoides, Lymphoma, T-Cell, Hematologic Neoplasms

NCT00019474 2018-09-14

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

60 enrolled

Bile Duct Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT00085436 2018-06-26

DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC

18 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01681446 2018-06-01

Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression

Phase 3 Unknown

296 enrolled

Carcinoma, Hepatocellular

NCT00055874 2018-05-03

Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

1,551 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00262951 2017-12-28

Chemoradiation in Locally Advanced Pancreatic Cancer

23 enrolled 8 charts

Pancreatic Neoplasms

NCT00005984 2017-11-29

Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

22 enrolled

Leukemia, Leukemia, Myeloid, Chronic-Phase

NCT00005986 2017-11-29

Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT00005987 2017-11-29

Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma

87 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00006244 2017-07-12

Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

36 enrolled 14 charts

Plasma cell

Multiple Myeloma

NCT00637117 2017-06-12

Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.

Phase 1/2 Withdrawn

Lymphoma

NCT00209209 2017-03-07

MCLelderly

Phase 3 Unknown

570 enrolled

Lymphoma, Mantle-Cell

NCT03069248 2017-03-03

Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon

36 enrolled

Lymphoma, Follicular

NCT02027064 2016-09-29

Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT

Phase 4 Unknown

40 enrolled

Leukemia, Myeloid, Acute

NCT00072046 2016-07-06

Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)

732 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00004104 2016-03-31

Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma

Melanoma

NCT00445523 2016-03-17

Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer

28 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00004039 2015-08-19

Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma

Phase 2 Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT00004040 2015-08-19

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Phase 2 Withdrawn

Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT00082719 2015-05-14

Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium

Phase 1 Completed

33 enrolled

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00011934 2014-04-17

Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT02074605 2014-02-28

Cognitive Effects of Interferon in Patients With Melanoma

Completed

36 enrolled

Melanoma

NCT00891475 2014-02-13

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

Phase 1/2 Completed

114 enrolled

Carcinoma, Renal Cell

NCT00004196 2014-01-20

Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis

3,000 enrolled

Melanoma

NCT00003585 2013-12-10

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Phase 1/2 Completed

35 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00002598 2013-06-25

Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

30 enrolled

Blast Crisis, Leukemia, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00045370 2013-06-05

Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Phase 1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00045422 2013-06-05

Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00447356 2013-05-13

High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

Phase 3 Withdrawn

Melanoma

NCT00660270 2013-04-23

Chemotherapy and Radiation Following Pancreatic Surgery

53 enrolled

Other solid neoplasmThoracic

Pancreatic Neoplasms

NCT00003263 2013-04-17

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Phase 1 Completed

6 enrolled

Mesothelioma, Malignant

NCT00004122 2013-02-01

BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer

Urinary Bladder Neoplasms

NCT00581425 2013-01-25

Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

Phase 4 Completed

49 enrolled

Carcinoma, Basal Cell, Facies

NCT00416871 2012-09-26

Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer

220 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00005615 2012-09-25

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Phase 1/2 Completed

24 enrolled

Melanoma

NCT00838968 2012-08-23

The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma

Phase NA Withdrawn

Carcinoma, Hepatocellular

NCT00504140 2012-08-02

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma